Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Performance Improvement in Healthcare: Is Personalized Site Feedback Enough?

Circulation. Cardiovascular quality and outcomes·2015
Same author

Financial stress and outcomes after acute myocardial infarction.

PloS one·2012
Same author

Statins: is it safe and effective to use generic "equivalents"?

The Canadian journal of cardiology·2012
Same author

Discontinuation of antihyperglycemic therapy after acute myocardial infarction: medical necessity or medical error?

Joint Commission journal on quality and patient safety·2012
Same author

Hospital patterns of use of positive inotropic agents in patients with heart failure.

Journal of the American College of Cardiology·2012
Same author

Duration of resuscitation efforts and survival after in-hospital cardiac arrest: an observational study.

Lancet (London, England)·2012

相关实验视频

Updated: May 13, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

医疗保健的财务障碍和急性心肌梗塞后的结果

Ali R Rahimi1, John A Spertus, Kimberly J Reid

  • 1Department of Medicine,Yale University School of Medicine, New Haven, Conn 06520-8088, USA. harlan.krumholz@yale.edu

JAMA
|March 16, 2007
PubMed
概括

医疗保健和药物的财务障碍显著恶化了急性心肌梗塞 (AMI) 后的康复. 患者面临更多的胸痛,生活质量下降,再住院风险增加,突出显示在AMI后护理中的关键差距.

科学领域:

  • 心脏病学 心脏病学
  • 医疗保健服务研究 医疗服务研究
  • 卫生经济学 卫生经济学

背景情况:

  • 医疗保健和药物的财务障碍很普遍,但在急性心肌梗塞 (AMI) 患者中缺乏研究.
  • 了解这些障碍对于改善AMI后患者的治疗结果至关重要.

研究的目的:

  • 确定AMI幸存者的医疗保健服务和药物的财务障碍的普遍性.
  • 评估这些财务障碍与12个月内随后的医疗保健结果之间的关联.

主要方法:

  • 预期注册评估心肌梗塞:事件和恢复 (PREMIER) 研究招募了2498名AMI后患者.
  • 收集的数据包括自我报告的财务障碍,健康状况 (SAQ,SF-12) 和12个月的再住院率.

主要成果:

  • 18.1%的人报告了医疗保健服务的财务障碍;12.9%的药物. 许多人有保险.
  • 财务障碍与较低的生活质量 (SAQ分数) 相关,并在1年的随访中增加了全因和心脏再住院率.
  • 药物障碍患者也报告了更多的胸痛,更差的生活质量和更高的再入院率.

结论:

  • 医疗保健服务和药物的财务障碍会对急性心肌梗塞后的康复产生负面影响.

更多相关视频

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

相关实验视频

Last Updated: May 13, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

  • 这些障碍与心痛增加,生活质量下降以及重新入院的风险增加有关.
  • 解决财务限制对于改善AMI患者的长期结果至关重要.